Xuezhen Zeng

1.3k total citations
18 papers, 474 citations indexed

About

Xuezhen Zeng is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Xuezhen Zeng has authored 18 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in Xuezhen Zeng's work include RNA modifications and cancer (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Xuezhen Zeng is often cited by papers focused on RNA modifications and cancer (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Xuezhen Zeng collaborates with scholars based in China, Hong Kong and United States. Xuezhen Zeng's co-authors include Alfred S.L. Cheng, Jingying Zhou, Simon E. Ward, Shuling Chen, Huichang Bi, Min Huang, Sui Peng, Yaoting Li, Ming Kuang and Dongshun Li and has published in prestigious journals such as Hepatology, Gut and British Journal of Pharmacology.

In The Last Decade

Xuezhen Zeng

16 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuezhen Zeng China 12 220 155 98 90 83 18 474
Ming–Heng Wu Taiwan 8 201 0.9× 77 0.5× 62 0.6× 108 1.2× 55 0.7× 9 435
Linlin Sun China 14 211 1.0× 85 0.5× 63 0.6× 91 1.0× 66 0.8× 25 459
Kam-Fai Lee Taiwan 9 187 0.8× 81 0.5× 40 0.4× 105 1.2× 51 0.6× 9 392
Pan Liu China 15 354 1.6× 105 0.7× 65 0.7× 233 2.6× 35 0.4× 32 554
Fengsheng Chen China 13 245 1.1× 104 0.7× 32 0.3× 89 1.0× 30 0.4× 44 461
Meijun Hao China 11 247 1.1× 139 0.9× 86 0.9× 61 0.7× 35 0.4× 17 452
Keerthi Kurma France 9 122 0.6× 99 0.6× 53 0.5× 72 0.8× 78 0.9× 17 302
Bénédicte Delire Belgium 8 178 0.8× 66 0.4× 30 0.3× 82 0.9× 148 1.8× 19 443

Countries citing papers authored by Xuezhen Zeng

Since Specialization
Citations

This map shows the geographic impact of Xuezhen Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuezhen Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuezhen Zeng more than expected).

Fields of papers citing papers by Xuezhen Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuezhen Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuezhen Zeng. The network helps show where Xuezhen Zeng may publish in the future.

Co-authorship network of co-authors of Xuezhen Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Xuezhen Zeng. A scholar is included among the top collaborators of Xuezhen Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuezhen Zeng. Xuezhen Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhang, Yuting, Jing Yang, Shuo Wang, et al.. (2025). Single‐Cell Transcriptomic Analysis Reveals an Aggressive Basal‐Like Tumor Cell Subpopulation Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma. Journal of Gastroenterology and Hepatology. 40(5). 1263–1273.
2.
Zeng, Xuezhen, et al.. (2024). Circulating inflammatory cytokines influencing schizophrenia: a Mendelian randomization study. Frontiers in Psychiatry. 15. 1417213–1417213. 4 indexed citations
3.
Li, Yaoting & Xuezhen Zeng. (2023). A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma. Frontiers in Pharmacology. 13. 1081952–1081952. 15 indexed citations
4.
Chen, Shuling, Junbin Liao, Zebin Chen, et al.. (2023). Hypoxia-driven tumor stromal remodeling and immunosuppressive microenvironment in scirrhous HCC. Hepatology. 79(4). 780–797. 33 indexed citations
5.
Liu, Hai‐Ning, Xuezhen Zeng, Xuxin Ren, et al.. (2022). Targeting tumour-intrinsic N 7 -methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy. Gut. 72(8). 1555–1567. 53 indexed citations
6.
Zeng, Xuezhen, Shumin Li, Haining Liu, et al.. (2022). Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation. Hepatology. 77(4). 1122–1138. 111 indexed citations
7.
Chen, Shuling, Xuezhen Zeng, Tianhong Su, et al.. (2022). Combinatory local ablation and immunotherapies for hepatocellular carcinoma: Rationale, efficacy, and perspective. Frontiers in Immunology. 13. 1033000–1033000. 26 indexed citations
8.
Zeng, Xuezhen, et al.. (2022). Identification of Pyroptosis Gene Signature Related Molecular Pattern,Clinical Implication, and Tumor Immunity in Hepatocellular Carcinoma`. Combinatorial Chemistry & High Throughput Screening. 26(7). 1324–1336. 1 indexed citations
9.
Xie, Wenxuan, Jiehui Tan, Бин Ли, et al.. (2021). Comparison of Hepatic Resection with Percutaneous Ablation for Hepatocellular Carcinoma in the Caudate Lobe Within Milan Criteria. Journal of Gastrointestinal Surgery. 26(2). 323–332. 1 indexed citations
10.
Zeng, Xuezhen, Simon E. Ward, Jingying Zhou, & Alfred S.L. Cheng. (2021). Liver Immune Microenvironment and Metastasis from Colorectal Cancer-Pathogenesis and Therapeutic Perspectives. Cancers. 13(10). 2418–2418. 45 indexed citations
11.
Han, Wei, Xiaoxuan Xu, Ran Li, et al.. (2020). HTLV screening of blood donors using chemiluminescence immunoassay in three major provincial blood centers of China. BMC Infectious Diseases. 20(1). 581–581. 7 indexed citations
12.
Zhou, Nan, Weixi Deng, Xuezhen Zeng, et al.. (2019). CIRDES: an efficient genome-wide method for in vivo RNA–RNA interactome analysis. The Analyst. 144(21). 6197–6206.
13.
Mok, Myth T.S., Jingying Zhou, Wenshu Tang, et al.. (2018). CCRK is a novel signalling hub exploitable in cancer immunotherapy. Pharmacology & Therapeutics. 186. 138–151. 38 indexed citations
14.
Li, Zhiheng, Jiahong Sun, Xiaomei Fan, et al.. (2017). Schisandrol B promotes liver regeneration after partial hepatectomy in mice. European Journal of Pharmacology. 818. 96–102. 29 indexed citations
15.
Chen, Pan, Dongshun Li, Yixin Chen, et al.. (2017). p53‐mediated regulation of bile acid disposition attenuates cholic acid‐induced cholestasis in mice. British Journal of Pharmacology. 174(23). 4345–4361. 22 indexed citations
16.
Zeng, Xuezhen, Xi Li, Chenshu Xu, et al.. (2017). Schisandra sphenanthera extract (Wuzhi Tablet) protects against chronic-binge and acute alcohol-induced liver injury by regulating the NRF2-ARE pathway in mice. Acta Pharmaceutica Sinica B. 7(5). 583–592. 44 indexed citations
17.
Li, Zhiheng, Xiaomei Fan, Dongshun Li, et al.. (2016). Schisandra sphenanthera Extract Facilitates Liver Regeneration after Partial Hepatectomy in Mice. Drug Metabolism and Disposition. 44(5). 647–652. 24 indexed citations
18.
Li, Yuhua, Ling Huang, Xuezhen Zeng, et al.. (2014). Down-regulation of P-gp expression and function after Mulberroside A treatment: Potential role of protein kinase C and NF-kappa B. Chemico-Biological Interactions. 213. 44–50. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026